Class 4 caution in use-Ocumont Eye Ointment 1% w/w

Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille information was inadvertently omitted during the approval and release process.

MHRA drug alert Date: 27/1/26

MHRA drug alert link: Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w, EL(26)A/03 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For all medical information enquiries and information on this product, please email info@blumontpharma.com, or telephone + 44 (0)1476 978 568.

For stock control enquiries please email info@blumontpharma.com, or telephone + 44 (0)1476 978 568.